Efficacy of St. John’s wort extract WS® 5570 in major depression – a double-blind, placebo-controlled trial

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European psychiatry

• Publication date

  2002-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0924-9338(02)80310-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• The Hamilton Rating Scales for Depression: A Critical Review of Clinimetric Properties of Different Versions

  2020cites this paper
• Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action

  2018cites this paper
• A meta-analysis on the efficacy and safety of St John’s wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults

  2016cites this paper
• A Perspective on Hypericum perforatum Genetic Transformation

  2016cites this paper
• A meta-analysis on the efficacy and safety of st John’s wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults

  2016cites this paper
• Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials

  2015influential citation
• Ähnlich stark wirksam wie synthetische Stoffe und besser verträglich?

  2015cites this paper
• Amended Safety Assessment of Hypericum Perforatum-Derived Ingredients as Used in Cosmetics

  2014cites this paper
• Study on the Separation and Preparation Technique of Phillyrin

  2014cites this paper
• Le millepertuis : état des lieux et enquête sur sa délivrance officinale en région Haute-Normandie

  2014cites this paper
• The Effect of St John’s Wort on the Pharmacokinetics of Docetaxel

  2013cites this paper
• Intervention Strategies For Depression

  2010influential citation
• What should medical practitioners know about the role of alternative medicines in cardiovascular disease management?

  2010cites this paper
• Chapter 4 St . John ’ s Wort : Quality Issues and Active Compounds

  2009cites this paper
• Transgenic Hypericum perforatum.

  2009cites this paper
• Efficacy of St. John’s wort extract WS® 5570 in acute treatment of mild depression

  2007cites this paper
• Placebo controlled continuation treatment with Hypericum extract WS® 5570 after recovery from a mild or moderate depressive episode

  2007cites this paper
• Hypericum perforatum Extrakt Ll 160: Ein Praxiserfahrungsbericht (PEB) über die Anwendung von Johanniskraut bei depressiven und körperlichen Beschwerden

  2006cites this paper
• Superior efficacy of St John's wort extract WS® 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

  2006influential citation
• Suïcidale en agressieve gedachten bij gebruik van hypericumpreparaat (sint-janskruid)

  2005cites this paper
• [Discussion on clinical efficacy of Hypericum perforatum for depression abroad].

  2004cites this paper
• Use of St John's wort (Hypericum perforatum L) in members of a depression self-help organisation: a 12-week open prospective pilot study using the HADS scale

  2004cites this paper
• Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products

  2004cites this paper
• Adverse effects of St. John's Wort: a systematic review.

  2004cites this paper
• Achieving the best outcome in treatment of depression.

  2003cites this paper
• Current St John's wort research from mode of action to clinical efficacy.

  2003cites this paper
• Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.

  2003cites this paper
• PMH40: EVALUATING THE COST-EFFECTIVENESS OF ST. JOHN'S WORT VERSUS FLUOXETINE FOR THE TREATMENT OF MILD TO MODERATE DEPRESSION

  2003cites this paper